11-13 November 2025
Congress Center BaselBasel, Switzerland Victor Goetz, PhDExecutive Director, TS/MS New Modalities at Eli Lilly and CompanySpeaker
Profile
Victor Goetz is an experienced monoclonal antibody manufacturing science leader recently bringing biologics experience to the domain of synthetic oligonucleotides, whose largely aqueous purification strongly resembles a biological process.
Agenda Sessions
Microbial Control Strategy to Support Oligonucleotide Solution APIs
, 15:00View Session